Synapse - Population Sciences Research Program

Results (11)

Genomic correlates of disease progression and treatment response in prospectively characterized gliomas

Journal Article

Jonsson, P.; Lin, A. L.; Young, R. J.; DiStefano, N. M.; Hyman, D. M.; Li, B. T.; Berger, M. F.; Zehir, A.; Ladanyi, M.; Solit, D. B.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Prospective genotyping of hepatocellular carcinoma: Clinical implications of next-generation sequencing for matching patients to targeted and immune therapies

Journal Article

Harding, J. J.; Nandakumar, S.; Armenia, J.; Khalil, D. N.; Albano, M.; Ly, M.; Shia, J.; Hechtman, J. F.; Kundra, R.; El Dika, I.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Time from prognosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma

Meeting Abstract

Soumerai, J. D.; Ni, A.; Batlevi, C.; Alperovich, A.; Bantilan, K. S.; Palomba, M.; Gerecitano, J. F.; Noy, A.; Hamlin, P.; Moskowitz, C. H.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save

Clinical and genetic determinants of ovarian metastases from colorectal cancer

Journal Article

Ganesh, K.; Shah, R. H.; Vakiani, E.; Nash, G. M.; Skottowe, H. P.; Yaeger, R.; Cercek, A.; Lincoln, A.; Tran, C.; Segal, N. H.; more...
Cancer (2017)

Fulltext@MSK | Save

Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era

Meeting Abstract

Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
Blood (2016)

Fulltext@MSK | Save

Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era

Meeting Abstract

Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
Blood (2016)

Fulltext@MSK | Save

Clinical prognostic factors and genomic analysis of ovary metastases (mets) from colorectal cancer (CRC)

Meeting Abstract

Ganesh, K.; Shah, R.; Vakiani, E.; Kemeny, N. E.; Lincoln, A.; Tran, C.; Varghese, A. M.; Yaeger, R. D.; Cercek, A.; Segal, N. H.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Reliable detection of mismatch repair deficiency in colorectal cancers using mutational load in next-generation sequencing panels

Journal Article

Stadler, Z. K.; Battaglin, F.; Middha, S.; Hechtman, J. F.; Tran, C.; Cercek, A.; Yaeger, R.; Segal, N. H.; Varghese, A. M.; Reidy-Lagunes, D. L.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Meeting Abstract

Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)

Meeting Abstract

Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save